Your browser doesn't support javascript.
loading
Establishment and clinical application of SARS-CoV-2 catch column.
Isaka, Yoshitaka; Yoshiya, Taku; Ono, Chikako; Uchiyama, Akinori; Hirata, Haruhiko; Hamaguchi, Shigeto; Kutsuna, Satoshi; Takabatake, Yoshitsugu; Saita, Ryotaro; Yamada, Tomomi; Takahashi, Atsushi; Yamato, Masaya; Nohara, Yukie; Tsuda, Shugo; Anzai, Itsuki; Kimura, Tomonori; Takeda, Yoshito; Tomono, Kazunori; Matsuura, Yoshiharu.
Affiliation
  • Isaka Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan. isaka@kid.med.osaka-u.ac.jp.
  • Yoshiya T; Peptide Institute Inc, Ibaraki, Japan.
  • Ono C; Institute for Protein Research, Osaka University, Suita, Japan.
  • Uchiyama A; Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Suita, Japan.
  • Hirata H; Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Hamaguchi S; Department of Intensive Care Unit, Osaka University Hospital, Suita, Japan.
  • Kutsuna S; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Takabatake Y; Department of Infection Control, Osaka University Hospital, Suita, Japan.
  • Saita R; Department of Infection Control, Osaka University Hospital, Suita, Japan.
  • Yamada T; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Takahashi A; Department of Medical Innovation, Osaka University Hospital, Suita, Japan.
  • Yamato M; Department of Medical Innovation, Osaka University Hospital, Suita, Japan.
  • Nohara Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Tsuda S; Division of General Internal Medicine and Infectious Diseases, Rinku General Medical Center, Izumisano, Japan.
  • Anzai I; Peptide Institute Inc, Ibaraki, Japan.
  • Kimura T; Peptide Institute Inc, Ibaraki, Japan.
  • Takeda Y; Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Tomono K; KAGAMI Project, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Japan.
  • Matsuura Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita, Japan.
Clin Exp Nephrol ; 27(3): 279-287, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36344716
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Exp Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Exp Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: